Perrigo Company / Omega Pharma Invest merger inquiry
The CMA investigated the anticipated acquisition by Perrigo Company plc of Omega Pharma Invest NV.
Statutory timetable
| Phase 1 date | Action |
|---|---|
| 9 April 2015 | Decision published |
| 9 March 2015 | Decision announced |
| 13 January 2015 to 26 January 2015 | Invitation to comment |
| 13 January 2015 | Launch of merger inquiry |
Phase 1
CMA clearance decision
9 March 2015: The CMA has cleared the anticipated acquisition by Perrigo Company plc of Omega Pharma Invest NV. The full text of the decision is available below.
- (9.4.15)
Launch of merger inquiry
13 January 2015: The CMA announced the launch of its merger inquiry by notice to the parties.
- (13.1.15)
Invitation to comment: Now closed
13 January 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
Contact
Please send written representations about any competition or public interest to:
Ronan Scanlan
Competition and Markets Authority
Victoria House
Southampton Row
London
WC1B 4AD
Updates to this page
Published 13 January 2015Last updated 9 April 2015 + show all updates
-
Full text of the decision published.
-
First published.